BIOG vs. MRCH, TFIF, NBPE, AGT.LN, JESC, ESCT, BGSC, GSCT, BLU, and SDP
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include The Merchants Trust (MRCH), TwentyFour Income (TFIF), NB Private Equity Partners (NBPE), AVI Global Trust (AGT.LN), JPMorgan European Smaller Companies Trust (JESC), The European Smaller Companies Trust (ESCT), BMO Global Smaller Companies (BGSC), The Global Smaller Companies Trust (GSCT), Blue Star Capital (BLU), and Schroder Investment Trust - Schroder AsiaPacific Fund (SDP). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs. Its Competitors
The Merchants Trust (LON:MRCH) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations.
6.1% of The Merchants Trust shares are held by institutional investors. Comparatively, 28.6% of The Biotech Growth Trust shares are held by institutional investors. 6.4% of The Merchants Trust shares are held by company insiders. Comparatively, 0.7% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
The Merchants Trust has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, The Biotech Growth Trust has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.
In the previous week, The Biotech Growth Trust had 4 more articles in the media than The Merchants Trust. MarketBeat recorded 5 mentions for The Biotech Growth Trust and 1 mentions for The Merchants Trust. The Biotech Growth Trust's average media sentiment score of 1.81 beat The Merchants Trust's score of 1.47 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.
The Merchants Trust has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than The Merchants Trust, indicating that it is currently the more affordable of the two stocks.
The Biotech Growth Trust has a net margin of 95.33% compared to The Merchants Trust's net margin of 90.97%. The Biotech Growth Trust's return on equity of 26.96% beat The Merchants Trust's return on equity.
The Biotech Growth Trust received 1 more outperform votes than The Merchants Trust when rated by MarketBeat users. Likewise, 64.06% of users gave The Biotech Growth Trust an outperform vote while only 55.48% of users gave The Merchants Trust an outperform vote.
Summary
The Biotech Growth Trust beats The Merchants Trust on 9 of the 15 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BIOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy BIOG Stock Free BIOG Stock Alerts